Show simple item record

dc.contributor.authorAli, FM
dc.contributor.authorFarah, N
dc.contributor.authorO’Dwyer, V
dc.contributor.authorO’Connor, C
dc.contributor.authorKennelly, MM
dc.contributor.authorTurner, MJ
dc.date.accessioned2013-02-26T12:19:29Z
dc.date.available2013-02-26T12:19:29Z
dc.date.issued2013-02
dc.identifier.urihttp://hdl.handle.net/10147/270477
dc.description.abstractGestational diabetes mellitus (GDM) has important maternal and fetal implications. In 2010, the Health Service Executive published guidelines on GDM. We examined the impact of the new guidelines in a large maternity unit. In January 2011, the hospital replaced the 100g Oral Glucose Tolerance Test (OGTT) with the new 75g OGTT. We compared the first 6 months of 2011 with the first 6 months of 2010. The new guidelines were associated with a 22% increase in women screened from 1375 in 2010 to 1679 in 2011 (p<0.001). Of the women screened, the number diagnosed with GDM increased from 10.1% (n=139) to 13.2% (n=221) (p<0.001).The combination of increased screening and a more sensitive OGTT resulted in the number of women diagnosed with GDM increasing 59% from 139 to 221 (p=0.02).This large increase has important resource implications but, if clinical outcomes are improved, there should be a decrease in long-term costs.
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.subjectDIABETES MELLITUSen_GB
dc.subjectPREGNANCY
dc.titleThe impact of new national guidelines on screening for gestational Diabetes Mellitusen_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen_GB
dc.description.provinceLeinsteren
refterms.dateFOA2018-08-23T03:49:46Z
html.description.abstractGestational diabetes mellitus (GDM) has important maternal and fetal implications. In 2010, the Health Service Executive published guidelines on GDM. We examined the impact of the new guidelines in a large maternity unit. In January 2011, the hospital replaced the 100g Oral Glucose Tolerance Test (OGTT) with the new 75g OGTT. We compared the first 6 months of 2011 with the first 6 months of 2010. The new guidelines were associated with a 22% increase in women screened from 1375 in 2010 to 1679 in 2011 (p<0.001). Of the women screened, the number diagnosed with GDM increased from 10.1% (n=139) to 13.2% (n=221) (p<0.001).The combination of increased screening and a more sensitive OGTT resulted in the number of women diagnosed with GDM increasing 59% from 139 to 221 (p=0.02).This large increase has important resource implications but, if clinical outcomes are improved, there should be a decrease in long-term costs.


Files in this item

Thumbnail
Name:
Article6579.pdf
Size:
20.48Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record